A murder charge rocked the country at the end of last year, with a highly publicized case playing out in 2025. Luigi Mangione was taken into federal custody on December 19, 2024, and charged with the ...

The U.S. has recorded 7,045 clinical Candida auris cases as of Dec. 20 — a 56.1% increase from the 4,514 cases logged in 2023, according to CDC data. About half of those cases are in Nevada and ...

A study by Case Western Reserve University and University Hospitals researchers has overturned long-held assumptions about why more cancer patients don’t enroll in clinical trials that could ...

In Dissent is a recurring series by Anastasia Boden on Supreme Court dissents that have shaped (or reshaped) our country. I. The artist formerly known as Prince It was 1981, and Prince was not yet ...

The iPhone 17 Pro and iPhone 17 Pro Max are Apple’s most powerful and feature-packed phones yet. In addition to bringing the usual compulsory hardware upgrades, both of the new flagship iPhones ...

The Case Comprehensive Cancer Center (Case CCC) is encouraging investigators to submit a project narrative for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available ...

ANN ARBOR, MI — Michigan Medicine and the University of Michigan Arts Initiative have teamed up to launch Michigan ArtsRx, a new clinical arts initiative to assist the mental health of students, UM ...

It’s that time of year when those upgrading to a new iPhone wonder if they can save a few bucks and stick their old case on a new phone. In recent years, it’s been unlikely. Last year was a prime ...

A scary new synthetic drug known as “purple fentanyl” is raising concern in Nebraska — and it is resistant to Narcan. Cops in Omaha are warning the public about the potentially deadly substance, which ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

REHOVOT, Israel, July 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT) ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...